We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+10.21%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$232M
AUM Growth
-$37.3M
Cap. Flow
-$107M
Cap. Flow %
-45.9%
Top 10 Hldgs %
59.19%
Holding
75
New
16
Increased
5
Reduced
5
Closed
41

Top Buys

Rank Stock Value
1
GTLS
Chart Industries
GTLS
+$16.1M
2
STZ icon
Constellation Brands
STZ
+$9.57M
3
ALIT icon
Alight
ALIT
+$8.16M
4
LAUR icon
Laureate Education
LAUR
+$7.54M
5
GTLS.PRB
Chart Industries 6.75% Series B Preferred Stock
GTLS.PRB
+$7.4M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$83.5M
2
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$31.6M
3
GOSS icon
Gossamer Bio
GOSS
+$8.31M
4
PM icon
Philip Morris
PM
+$5.4M
5
CRBG icon
Corebridge Financial
CRBG
+$4.92M

Sector Composition

Rank Sector Weight
1 Healthcare 19.43%
2 Consumer Staples 6.88%
3 Industrials 5.72%
4 Technology 4.4%
5 Energy 2.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THRD
51
DELISTED
Third Harmonic Bio
THRD
– –
-40,000
Closed -$759K
TSVT
52
DELISTED
2seventy bio
TSVT
– –
-70,000
Closed -$1.02M
AMPS
53
DELISTED
Altus Power
AMPS
– –
-108,700
Closed -$1.2M
PYCR
54
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
– –
-35,000
Closed -$1.03M
RVNC
55
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-85,000
Closed -$2.29M
ALPN
56
DELISTED
Alpine Immune Sciences Inc
ALPN
– –
-100,000
Closed -$720K
KDNY
57
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-95,000
Closed -$1.87M
FRC
58
DELISTED
First Republic Bank
FRC
– –
-10,000
Closed -$1.31M
CINC
59
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
– –
-30,000
Closed -$985K
KNBE
60
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
– –
-10,000
Closed -$208K
1 2
3

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, Monashee Investment Management held 75 positions worth $232M, down 14% from $270M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Monashee Investment Management withdrew a net $107M in Q4 2022, closing 41 positions and reducing 5 holdings. Its most notable exit was Gossamer Bio, an estimated $8.31M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Consumer Staples and Industrials.

Against the trend, Monashee Investment Management opened a new position in Chart Industries worth $11.5M.

  • Monashee Investment Management's largest Q4 2022 buy was Chart Industries: 100,000 shares worth $11.5M.
  • Monashee Investment Management added most to Compass Therapeutics in Q4 2022, an estimated $3.99M increase.
  • Monashee Investment Management's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $83.5M.
  • Monashee Investment Management fully exited Gossamer Bio in Q4 2022, selling an estimated $8.31M.
  • Monashee Investment Management's ten largest holdings make up 59% of its $232M portfolio in Q4 2022.
  • Monashee Investment Management opened 16 new positions and closed 41 in Q4 2022.
  • Monashee Investment Management's portfolio value fell 14% quarter-over-quarter to $232M.

Based on Monashee Investment Management's 13F filing for Q4 2022, filed 9 Feb 2023.